AbbVie
ABBV
#28
Rank
$335.20 B
Marketcap
$189.77
Share price
1.14%
Change (1 day)
13.96%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of July 2025 (TTM): 5.84

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 229. At the end of 2025 the company had a P/S ratio of 6.33.

P/S ratio history for AbbVie from 2012 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20256.3313.37%
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.33-60.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.01-65.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.2 143.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
4.68-19.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
4.81-17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2.01-65.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
1.93-67.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
4.01-31.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
5.28-9.62%๐Ÿ‡บ๐Ÿ‡ธ USA